Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gemofer is an oral hematinic supplement developed and marketed by Allgems Healthcare, primarily indicated for the treatment and prevention of iron deficiency anemia. It is a combination product typically composed of ferrous ascorbate, folic acid (Vitamin B9), and zinc sulfate. Ferrous ascorbate is a synthetic chelate of ferrous iron and ascorbic acid that provides high elemental iron bioavailability with improved gastrointestinal tolerance compared to traditional iron salts. Folic acid is essential for DNA synthesis and the maturation of red blood cells, helping to prevent megaloblastic anemia. Zinc sulfate acts as a cofactor for numerous enzymes involved in cellular metabolism and immune function. Gemofer is commonly used to manage nutritional deficiencies, anemia during pregnancy and lactation, and recovery from chronic blood loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous ascorbate + folic acid + zinc sulfate.